| Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways RP Nair, KC Duffin, C Helms, J Ding, PE Stuart, D Goldgar, ... Nature genetics 41 (2), 199-204, 2009 | 1687 | 2009 |
| Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity LC Tsoi, SL Spain, J Knight, E Ellinghaus, PE Stuart, F Capon, J Ding, ... Nature genetics 44 (12), 1341-1348, 2012 | 1120 | 2012 |
| 2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism/American College of … A Ravelli, F Minoia, S Davì, AC Horne, F Bovis, A Pistorio, M Aricò, ... Annals of the Rheumatic Diseases 75 (3), 481-489, 2016 | 955 | 2016 |
| Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis A Hinks, J Cobb, MC Marion, S Prahalad, M Sudman, J Bowes, P Martin, ... Nature genetics 45 (6), 664-669, 2013 | 462 | 2013 |
| Consensus treatment plans for new‐onset systemic juvenile idiopathic arthritis EM Dewitt, Y Kimura, T Beukelman, PA Nigrovic, K Onel, S Prahalad, ... Arthritis care & research 64 (7), 1001-1010, 2012 | 265 | 2012 |
| A comprehensive review of the genetics of juvenile idiopathic arthritis S Prahalad, DN Glass Pediatric Rheumatology 6, 1-16, 2008 | 227 | 2008 |
| Etanercept in the treatment of macrophage activation syndrome. S Prahalad, KE Bove, D Dickens, DJ Lovell, AA Grom The Journal of rheumatology 28 (9), 2120-2124, 2001 | 216 | 2001 |
| Emergent high fatality lung disease in systemic juvenile arthritis VE Saper, G Chen, GH Deutsch, RP Guillerman, J Birgmeier, ... Annals of the rheumatic diseases 78 (12), 1722-1731, 2019 | 204 | 2019 |
| Increased prevalence of familial autoimmunity in simplex and multiplex families with juvenile rheumatoid arthritis S Prahalad, ES Shear, SD Thompson, EH Giannini, DN Glass Arthritis & Rheumatism: Official Journal of the American College of …, 2002 | 204 | 2002 |
| Immunogenetics of juvenile idiopathic arthritis: A comprehensive review AO Hersh, S Prahalad Journal of autoimmunity 64, 113-124, 2015 | 200 | 2015 |
| Age‐specific effects of juvenile rheumatoid arthritis–associated HLA alleles KJ Murray, MB Moroldo, P Donnelly, S Prahalad, MH Passo, EH Giannini, ... Arthritis & Rheumatism: Official Journal of the American College of …, 1999 | 187 | 1999 |
| HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis MJ Ombrello, EF Remmers, I Tachmazidou, A Grom, D Foell, JP Haas, ... Proceedings of the National Academy of Sciences 112 (52), 15970-15975, 2015 | 183 | 2015 |
| Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications MJ Ombrello, VL Arthur, EF Remmers, A Hinks, I Tachmazidou, AA Grom, ... Annals of the rheumatic diseases 76 (5), 906-913, 2017 | 181 | 2017 |
| The susceptibility loci juvenile idiopathic arthritis shares with other autoimmune diseases extend to PTPN2, COG6, and ANGPT1 SD Thompson, M Sudman, PS Ramos, MC Marion, M Ryan, M Tsoras, ... Arthritis & Rheumatism 62 (11), 3265-3276, 2010 | 169 | 2010 |
| Risk markers of juvenile idiopathic arthritis-associated uveitis in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry ST Angeles-Han, CF Pelajo, LB Vogler, K Rouster-Stevens, C Kennedy, ... The Journal of rheumatology 40 (12), 2088-2096, 2013 | 159 | 2013 |
| Childhood Arthritis and Rheumatology Research Alliance consensus treatment plans for new‐onset polyarticular juvenile idiopathic arthritis S Ringold, PF Weiss, RA Colbert, EM DeWitt, T Lee, K Onel, S Prahalad, ... Arthritis care & research 66 (7), 1063-1072, 2014 | 145 | 2014 |
| Anakinra for systemic juvenile arthritis: the Rocky Mountain experience A Zeft, R Hollister, B LaFleur, P Sampath, J Soep, B McNally, G Kunkel, ... JCR: Journal of Clinical Rheumatology 15 (4), 161-164, 2009 | 145 | 2009 |
| Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trial N Ruperto, HI Brunner, O Synoverska, TV Ting, CA Mendoza, A Spindler, ... The Lancet 398 (10315), 1984-1996, 2021 | 144 | 2021 |
| Negative association between the chemokine receptor CCR5-Δ32 polymorphism and rheumatoid arthritis: a meta-analysis S Prahalad Genes & Immunity 7 (3), 264-268, 2006 | 136 | 2006 |
| Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis S Davì, F Minoia, A Pistorio, AC Horne, A Consolaro, S Rosina, F Bovis, ... Arthritis & rheumatology 66 (10), 2871-2880, 2014 | 135 | 2014 |
